#CancerBS #ChronicIllness #NEISvoid
emilysuess.com/2019/11/20/h...
Follow along for the best of #ASCO25
Top 10 trials in #GIonc and #pallonc are incoming 🔮
@oncoalert.bsky.social
@weoncologists.bsky.social
@pallonccop.bsky.social
@biagioricciutimd.bsky.social
@drnataliagandur.bsky.social
@elisabettabonzano.bsky.social
@kjankovic.bsky.social
Follow along for the best of #ASCO25
Top 10 trials in #GIonc and #pallonc are incoming 🔮
@oncoalert.bsky.social
@weoncologists.bsky.social
@pallonccop.bsky.social
@biagioricciutimd.bsky.social
@drnataliagandur.bsky.social
@elisabettabonzano.bsky.social
@kjankovic.bsky.social
@oncoalert.bsky.social
@weoncologists.bsky.social
@pallonccop.bsky.social
@joanmancusombc.bsky.social
@oncoalert.bsky.social
@weoncologists.bsky.social
@pallonccop.bsky.social
@joanmancusombc.bsky.social
@docwithbowtie.bsky.social
@engagetheo.bsky.social
@therealdsrini.bsky.social
@djweiner.bsky.social
@stephjantzen.bsky.social
@docwithbowtie.bsky.social
@engagetheo.bsky.social
@therealdsrini.bsky.social
@djweiner.bsky.social
@stephjantzen.bsky.social
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@elisabettabonzano.bsky.social
@elisaagostinetto.bsky.social
@oncoalert.bsky.social
@weoncologists.bsky.social
MedSky OncSky OncoSky CanSky GIonc
Today on #WorldCancerDay, I continue in my quest to unite cancer care and support. We have a long way yet to go:
✨ ⬆️ Quality
✨ ⬇️ Cost 💰
✨ Equitable access
✨ ⬆️ #SurvOnc
@oncoalert.bsky.social
@weoncologists.bsky.social
@pallonccop.bsky.social
Today on #WorldCancerDay, I continue in my quest to unite cancer care and support. We have a long way yet to go:
✨ ⬆️ Quality
✨ ⬇️ Cost 💰
✨ Equitable access
✨ ⬆️ #SurvOnc
@oncoalert.bsky.social
@weoncologists.bsky.social
@pallonccop.bsky.social
@therealdsrini.medsky.social
@drdonsdizon.bsky.social
@jasawebb.bsky.social
@djweiner.bsky.social
@stephjantzen.bsky.social
@zachradcliffphd.bsky.social
@therealdsrini.medsky.social
@drdonsdizon.bsky.social
@jasawebb.bsky.social
@djweiner.bsky.social
@stephjantzen.bsky.social
@zachradcliffphd.bsky.social
@docwithbowtie.bsky.social
@engagetheo.bsky.social
@djweiner.bsky.social
@stephjantzen.bsky.social
@zachradcliffphd.bsky.social
@rubinallergy.bsky.social
@docwithbowtie.bsky.social
@engagetheo.bsky.social
@djweiner.bsky.social
@stephjantzen.bsky.social
@zachradcliffphd.bsky.social
@rubinallergy.bsky.social
🔗 buff.ly/OY4vsiV
🔗 buff.ly/OY4vsiV
#ctDNA helps detects #MRD for #dMMR stage III #crcsm it can guide treatment shifts:
ineffective chemo ➡️ #immunotherapy 🟰 ⬆️ outcomes
🔗: www.tandfonline.com/doi/full/10....
#ctDNA helps detects #MRD for #dMMR stage III #crcsm it can guide treatment shifts:
ineffective chemo ➡️ #immunotherapy 🟰 ⬆️ outcomes
🔗: www.tandfonline.com/doi/full/10....
@oncoalert.bsky.social
@weoncologists.bsky.social
@pallonccop.bsky.social
@biagioricciutimd.bsky.social
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@realbowtiedoc.bsky.social
@arosen380.bsky.social
Ping
@gillsharlene.bsky.social
@oncoalert.bsky.social
@weoncologists.bsky.social
@pallonccop.bsky.social
@biagioricciutimd.bsky.social
Starting with #PancreaticCancer and Ras⛔️
Actually only2⃣titles I saw:
1⃣Ignacio Garrido-Laguna🗣️ctDNA🩸changes in the Ph1 trial of the Ras(on)⛔️RMC-6236 Abs 722; Poster#H10
2⃣Alex Spira🗣️a Ph1 trial of the G12D specific⛔️RMC-9805 Abs 724; Poster#H12
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GastroesophagealAdenocarcinoma #GIOnc
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GastroesophagealAdenocarcinoma #GIOnc
GI cancers attributable to #alcohol drinking #ESMOAmbassadors #GIOnc @myesmo.bsky.social
GI cancers attributable to #alcohol drinking #ESMOAmbassadors #GIOnc @myesmo.bsky.social